Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse

Name: Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse
Published: 2022
License: Public Domain

Zhujiang Hospital · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

acute leukemia myeloid

leukemia, myeloid, acute, acute myelogenous leukemia, allogenetic stem cell transplant, maintenance therapy, azacitidine, chidamide, high-risk aml, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse

Related documents